Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

TELA Bio (TELA) Cost of Revenue (2018 - 2025)

TELA Bio (TELA) has 8 years of Cost of Revenue data on record, last reported at $6.6 million in Q3 2025.

  • For Q3 2025, Cost of Revenue fell 59.78% year-over-year to $6.6 million; the TTM value through Sep 2025 reached $43.2 million, down 55.79%, while the annual FY2024 figure was $64.6 million, 8.32% up from the prior year.
  • Cost of Revenue reached $6.6 million in Q3 2025 per TELA's latest filing, up from $6.0 million in the prior quarter.
  • Across five years, Cost of Revenue topped out at $47.0 million in Q4 2023 and bottomed at -$10.4 million in Q4 2021.
  • Average Cost of Revenue over 5 years is $11.1 million, with a median of $11.1 million recorded in 2022.
  • Peak YoY movement for Cost of Revenue: plummeted 263.13% in 2021, then soared 805.04% in 2022.
  • A 5-year view of Cost of Revenue shows it stood at -$10.4 million in 2021, then skyrocketed by 211.96% to $11.6 million in 2022, then skyrocketed by 303.53% to $47.0 million in 2023, then crashed by 70.3% to $14.0 million in 2024, then tumbled by 52.53% to $6.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cost of Revenue were $6.6 million in Q3 2025, $6.0 million in Q2 2025, and $16.6 million in Q1 2025.